[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Transforming Growth Factor Beta 2 Market Report 2018

March 2018 | 96 pages | ID: U2AB8399F00QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Transforming Growth Factor Beta 2 market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Transforming Growth Factor Beta 2 in these regions, from 2013 to 2025 (forecast).
United States Transforming Growth Factor Beta 2 market competition by top manufacturers/players, with Transforming Growth Factor Beta 2 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Autotelic Inc
  • Genzyme Corp
  • Isarna Therapeutics GmbH
  • Novartis AG
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • XOMA-089
  • Trabedersen
  • ISTH-0047
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Glioblastoma Multiforme
  • Open-Angle Glaucoma
  • Liver Fibrosis
  • Melanoma
  • Breast Cancer
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Transforming Growth Factor Beta 2 Market Report 2018

1 TRANSFORMING GROWTH FACTOR BETA 2 OVERVIEW

1.1 Product Overview and Scope of Transforming Growth Factor Beta
1.2 Classification of Transforming Growth Factor Beta 2 by Product Category
  1.2.1 United States Transforming Growth Factor Beta 2 Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Transforming Growth Factor Beta 2 Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 XOMA-089
  1.2.4 Trabedersen
  1.2.5 ISTH-0047
  1.2.6 Others
1.3 United States Transforming Growth Factor Beta 2 Market by Application/End Users
  1.3.1 United States Transforming Growth Factor Beta 2 Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Glioblastoma Multiforme
  1.3.3 Open-Angle Glaucoma
  1.3.4 Liver Fibrosis
  1.3.5 Melanoma
  1.3.6 Breast Cancer
  1.3.7 Others
1.4 United States Transforming Growth Factor Beta 2 Market by Region
  1.4.1 United States Transforming Growth Factor Beta 2 Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Transforming Growth Factor Beta 2 Status and Prospect (2013-2025)
  1.4.3 Southwest Transforming Growth Factor Beta 2 Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Transforming Growth Factor Beta 2 Status and Prospect (2013-2025)
  1.4.5 New England Transforming Growth Factor Beta 2 Status and Prospect (2013-2025)
  1.4.6 The South Transforming Growth Factor Beta 2 Status and Prospect (2013-2025)
  1.4.7 The Midwest Transforming Growth Factor Beta 2 Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Transforming Growth Factor Beta 2 (2013-2025)
  1.5.1 United States Transforming Growth Factor Beta 2 Sales and Growth Rate (2013-2025)
  1.5.2 United States Transforming Growth Factor Beta 2 Revenue and Growth Rate (2013-2025)

2 UNITED STATES TRANSFORMING GROWTH FACTOR BETA 2 MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Transforming Growth Factor Beta 2 Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Transforming Growth Factor Beta 2 Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Transforming Growth Factor Beta 2 Average Price by Players/Suppliers (2013-2018)
2.4 United States Transforming Growth Factor Beta 2 Market Competitive Situation and Trends
  2.4.1 United States Transforming Growth Factor Beta 2 Market Concentration Rate
  2.4.2 United States Transforming Growth Factor Beta 2 Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Transforming Growth Factor Beta 2 Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES TRANSFORMING GROWTH FACTOR BETA 2 SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Transforming Growth Factor Beta 2 Sales and Market Share by Region (2013-2018)
3.2 United States Transforming Growth Factor Beta 2 Revenue and Market Share by Region (2013-2018)
3.3 United States Transforming Growth Factor Beta 2 Price by Region (2013-2018)

4 UNITED STATES TRANSFORMING GROWTH FACTOR BETA 2 SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Transforming Growth Factor Beta 2 Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Transforming Growth Factor Beta 2 Revenue and Market Share by Type (2013-2018)
4.3 United States Transforming Growth Factor Beta 2 Price by Type (2013-2018)
4.4 United States Transforming Growth Factor Beta 2 Sales Growth Rate by Type (2013-2018)

5 UNITED STATES TRANSFORMING GROWTH FACTOR BETA 2 SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Transforming Growth Factor Beta 2 Sales and Market Share by Application (2013-2018)
5.2 United States Transforming Growth Factor Beta 2 Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES TRANSFORMING GROWTH FACTOR BETA 2 PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Autotelic Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Transforming Growth Factor Beta 2 Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Autotelic Inc Transforming Growth Factor Beta 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Genzyme Corp
  6.2.2 Transforming Growth Factor Beta 2 Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Genzyme Corp Transforming Growth Factor Beta 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Isarna Therapeutics GmbH
  6.3.2 Transforming Growth Factor Beta 2 Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Novartis AG
  6.4.2 Transforming Growth Factor Beta 2 Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis AG Transforming Growth Factor Beta 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview

7 TRANSFORMING GROWTH FACTOR BETA 2 MANUFACTURING COST ANALYSIS

7.1 Transforming Growth Factor Beta 2 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transforming Growth Factor Beta

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Transforming Growth Factor Beta 2 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transforming Growth Factor Beta 2 Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES TRANSFORMING GROWTH FACTOR BETA 2 MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Transforming Growth Factor Beta 2 Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Transforming Growth Factor Beta 2 Sales Volume Forecast by Type (2018-2025)
11.3 United States Transforming Growth Factor Beta 2 Sales Volume Forecast by Application (2018-2025)
11.4 United States Transforming Growth Factor Beta 2 Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Transforming Growth Factor Beta
Figure United States Transforming Growth Factor Beta 2 Market Size (K Pcs) by Type (2013-2025)
Figure United States Transforming Growth Factor Beta 2 Sales Volume Market Share by Type (Product Category) in 2017
Figure XOMA-089 Product Picture
Figure Trabedersen Product Picture
Figure ISTH-0047 Product Picture
Figure Others Product Picture
Figure United States Transforming Growth Factor Beta 2 Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Transforming Growth Factor Beta 2 by Application in 2017
Figure Glioblastoma Multiforme Examples
Table Key Downstream Customer in Glioblastoma Multiforme
Figure Open-Angle Glaucoma Examples
Table Key Downstream Customer in Open-Angle Glaucoma
Figure Liver Fibrosis Examples
Table Key Downstream Customer in Liver Fibrosis
Figure Melanoma Examples
Table Key Downstream Customer in Melanoma
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Transforming Growth Factor Beta 2 Market Size (Million USD) by Region (2013-2025)
Figure The West Transforming Growth Factor Beta 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Transforming Growth Factor Beta 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Transforming Growth Factor Beta 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Transforming Growth Factor Beta 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Transforming Growth Factor Beta 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Transforming Growth Factor Beta 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Transforming Growth Factor Beta 2 Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Transforming Growth Factor Beta 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Transforming Growth Factor Beta 2 Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Transforming Growth Factor Beta 2 Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Transforming Growth Factor Beta 2 Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Transforming Growth Factor Beta 2 Sales Share by Players/Suppliers
Figure 2017 United States Transforming Growth Factor Beta 2 Sales Share by Players/Suppliers
Figure United States Transforming Growth Factor Beta 2 Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Transforming Growth Factor Beta 2 Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Transforming Growth Factor Beta 2 Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Transforming Growth Factor Beta 2 Revenue Share by Players/Suppliers
Figure 2017 United States Transforming Growth Factor Beta 2 Revenue Share by Players/Suppliers
Table United States Market Transforming Growth Factor Beta 2 Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Transforming Growth Factor Beta 2 Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Transforming Growth Factor Beta 2 Market Share of Top 3 Players/Suppliers
Figure United States Transforming Growth Factor Beta 2 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Transforming Growth Factor Beta 2 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Transforming Growth Factor Beta 2 Product Category
Table United States Transforming Growth Factor Beta 2 Sales (K Pcs) by Region (2013-2018)
Table United States Transforming Growth Factor Beta 2 Sales Share by Region (2013-2018)
Figure United States Transforming Growth Factor Beta 2 Sales Share by Region (2013-2018)
Figure United States Transforming Growth Factor Beta 2 Sales Market Share by Region in 2017
Table United States Transforming Growth Factor Beta 2 Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Transforming Growth Factor Beta 2 Revenue Share by Region (2013-2018)
Figure United States Transforming Growth Factor Beta 2 Revenue Market Share by Region (2013-2018)
Figure United States Transforming Growth Factor Beta 2 Revenue Market Share by Region in 2017
Table United States Transforming Growth Factor Beta 2 Price (USD/Pcs) by Region (2013-2018)
Table United States Transforming Growth Factor Beta 2 Sales (K Pcs) by Type (2013-2018)
Table United States Transforming Growth Factor Beta 2 Sales Share by Type (2013-2018)
Figure United States Transforming Growth Factor Beta 2 Sales Share by Type (2013-2018)
Figure United States Transforming Growth Factor Beta 2 Sales Market Share by Type in 2017
Table United States Transforming Growth Factor Beta 2 Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Transforming Growth Factor Beta 2 Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Transforming Growth Factor Beta 2 by Type (2013-2018)
Figure Revenue Market Share of Transforming Growth Factor Beta 2 by Type in 2017
Table United States Transforming Growth Factor Beta 2 Price (USD/Pcs) by Types (2013-2018)
Figure United States Transforming Growth Factor Beta 2 Sales Growth Rate by Type (2013-2018)
Table United States Transforming Growth Factor Beta 2 Sales (K Pcs) by Application (2013-2018)
Table United States Transforming Growth Factor Beta 2 Sales Market Share by Application (2013-2018)
Figure United States Transforming Growth Factor Beta 2 Sales Market Share by Application (2013-2018)
Figure United States Transforming Growth Factor Beta 2 Sales Market Share by Application in 2017
Table United States Transforming Growth Factor Beta 2 Sales Growth Rate by Application (2013-2018)
Figure United States Transforming Growth Factor Beta 2 Sales Growth Rate by Application (2013-2018)
Table Autotelic Inc Basic Information List
Table Autotelic Inc Transforming Growth Factor Beta 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Autotelic Inc Transforming Growth Factor Beta 2 Sales Growth Rate (2013-2018)
Figure Autotelic Inc Transforming Growth Factor Beta 2 Sales Market Share in United States (2013-2018)
Figure Autotelic Inc Transforming Growth Factor Beta 2 Revenue Market Share in United States (2013-2018)
Table Genzyme Corp Basic Information List
Table Genzyme Corp Transforming Growth Factor Beta 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genzyme Corp Transforming Growth Factor Beta 2 Sales Growth Rate (2013-2018)
Figure Genzyme Corp Transforming Growth Factor Beta 2 Sales Market Share in United States (2013-2018)
Figure Genzyme Corp Transforming Growth Factor Beta 2 Revenue Market Share in United States (2013-2018)
Table Isarna Therapeutics GmbH Basic Information List
Table Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Sales Growth Rate (2013-2018)
Figure Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Sales Market Share in United States (2013-2018)
Figure Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Revenue Market Share in United States (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Transforming Growth Factor Beta 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis AG Transforming Growth Factor Beta 2 Sales Growth Rate (2013-2018)
Figure Novartis AG Transforming Growth Factor Beta 2 Sales Market Share in United States (2013-2018)
Figure Novartis AG Transforming Growth Factor Beta 2 Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transforming Growth Factor Beta
Figure Manufacturing Process Analysis of Transforming Growth Factor Beta
Figure Transforming Growth Factor Beta 2 Industrial Chain Analysis
Table Raw Materials Sources of Transforming Growth Factor Beta 2 Major Players/Suppliers in 2017
Table Major Buyers of Transforming Growth Factor Beta
Table Distributors/Traders List
Figure United States Transforming Growth Factor Beta 2 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Transforming Growth Factor Beta 2 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Transforming Growth Factor Beta 2 Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Transforming Growth Factor Beta 2 Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Transforming Growth Factor Beta 2 Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Transforming Growth Factor Beta 2 Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Transforming Growth Factor Beta 2 Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Transforming Growth Factor Beta 2 Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Transforming Growth Factor Beta 2 Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Transforming Growth Factor Beta 2 Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Transforming Growth Factor Beta 2 Sales Volume Share Forecast by Region (2018-2025)
Figure United States Transforming Growth Factor Beta 2 Sales Volume Share Forecast by Region (2018-2025)
Figure United States Transforming Growth Factor Beta 2 Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories